These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. Ge J, Chen Z, Wu S, Yuan W, Hu B, Chen Z. Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622 [Abstract] [Full Text] [Related]
3. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. Kim HS, Lee JS, Freund JN, Min KW, Lee JS, Kim W, Juhng SW, Park CS. J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871 [Abstract] [Full Text] [Related]
5. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion. Maehata Y, Hirahashi M, Aishima S, Kishimoto J, Hirohashi S, Yao T, Takashima H, Tsuneyoshi M, Oda Y. Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043 [Abstract] [Full Text] [Related]
7. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. Ko S, Chu KM, Luk JM, Wong BW, Yuen ST, Leung SY, Wong J. J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140 [Abstract] [Full Text] [Related]
9. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Fan Z, Li J, Dong B, Huang X. Clin Cancer Res; 2005 Sep 01; 11(17):6162-70. PubMed ID: 16144916 [Abstract] [Full Text] [Related]
11. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma. Hu L, Li HL, Li WF, Chen JM, Yang JT, Gu JJ, Xin L. World J Gastroenterol; 2017 May 28; 23(20):3721-3729. PubMed ID: 28611525 [Abstract] [Full Text] [Related]
13. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K. Br J Surg; 2002 Feb 28; 89(2):236-44. PubMed ID: 11856141 [Abstract] [Full Text] [Related]
14. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M, Lee HK, Kang YK. Anticancer Res; 2003 Feb 28; 23(2B):1581-8. PubMed ID: 12820426 [Abstract] [Full Text] [Related]
15. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma]. Zhou YN, Xu CP, Han B, Ji R. Ai Zheng; 2005 Oct 28; 24(10):1220-4. PubMed ID: 16219136 [Abstract] [Full Text] [Related]
16. Protein expression status in mucosal and submucosal portions of early gastric cancers and their predictive value for lymph node metastasis. Lee KB, Park DJ, Choe G, Kim HH, Kim WH, Lee HS. APMIS; 2013 Oct 28; 121(10):926-37. PubMed ID: 23758612 [Abstract] [Full Text] [Related]
17. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers. Boo YJ, Park SS, Kim JH, Mok YJ, Kim SJ, Kim CS. J Surg Oncol; 2007 Feb 01; 95(2):110-7. PubMed ID: 17066436 [Abstract] [Full Text] [Related]
18. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. Gao H, Lan X, Li S, Xue Y. Tumour Biol; 2017 May 01; 39(5):1010428317698368. PubMed ID: 28459196 [Abstract] [Full Text] [Related]
19. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Cancer; 2000 Aug 15; 89(4):724-32. PubMed ID: 10951333 [Abstract] [Full Text] [Related]